Serbia's national privatisation agency has announced that it is no longer selling its 70% stake in Galenika, the country's largest pharmaceutical manufacturer, and that no tenders will be organised this year. It said that no bidders could meet the requirements it had outlined.
The agency issued its latest invitation to bid for the stake last December, hoping to raise at least €200 million,...






